CD8A and neoplasm: Previous studies focused on tumor-associated immune cells (TAICs) and their role in cancer recurrence did not produce consistent results, e.g., Choueri et al. reported poorer prognosis in patients with increased CD8 + T cells (Choueiri et al. 2015), while Weiss et al. presented contradictory observations (Weiss et al. 2014).